Cargando…

Cytoreductive nephrectomy for metastatic renal cell carcinoma: inequities in access exist despite improved survival

The use of cytoreductive nephrectomy (CRN) in the targeted therapy era is still debated. We aimed to determine factors associated with reduced use of CRN and determine the effect of CRN on overall survival in patients with metastatic renal cell carcinoma (RCC). All advanced RCC diagnosed between 200...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Manish I., Beattie, Kieran, Bang, Albert, Gurney, Howard, Smith, David P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633591/
https://www.ncbi.nlm.nih.gov/pubmed/28834281
http://dx.doi.org/10.1002/cam4.1137